Second dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series.

Aled Iaboni,Nina Jindal,Stephen D. Betschel,Christine Song

Journal of Allergy and Clinical Immunology: Global（2022）

引用 1|浏览1

暂无评分

摘要

Our case series adds to current evidence that administration of a second COVID-19 mRNA vaccine dose has a good safety profile in patients with a history of immediate reactions after the first dose, including those with a history of anaphylaxis in response to the first dose.

查看译文

关键词

Coronavirus disease 2019,COVID-19,mRNA,vaccine,anaphylaxis,allergy,Pfizer,Moderna

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要